These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27585757)

  • 21. Early Invasive Strategy and In-Hospital Survival Among Diabetics With Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight.
    Mahmoud AN; Elgendy IY; Mansoor H; Wen X; Mojadidi MK; Bavry AA; Anderson RD
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28315826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.
    Valgimigli M; Gagnor A; Calabró P; Frigoli E; Leonardi S; Zaro T; Rubartelli P; Briguori C; Andò G; Repetto A; Limbruno U; Cortese B; Sganzerla P; Lupi A; Galli M; Colangelo S; Ierna S; Ausiello A; Presbitero P; Sardella G; Varbella F; Esposito G; Santarelli A; Tresoldi S; Nazzaro M; Zingarelli A; de Cesare N; Rigattieri S; Tosi P; Palmieri C; Brugaletta S; Rao SV; Heg D; Rothenbühler M; Vranckx P; Jüni P;
    Lancet; 2015 Jun; 385(9986):2465-76. PubMed ID: 25791214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.
    Savonitto S; Cavallini C; Petronio AS; Murena E; Antonicelli R; Sacco A; Steffenino G; Bonechi F; Mossuti E; Manari A; Tolaro S; Toso A; Daniotti A; Piscione F; Morici N; Cesana BM; Jori MC; De Servi S;
    JACC Cardiovasc Interv; 2012 Sep; 5(9):906-16. PubMed ID: 22995877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timing of invasive strategy in diabetic and non-diabetic patients with non-ST-segment elevation acute coronary syndrome.
    Dimitrov NG; Simova II; Mateev HF; Kalpachka MR; Pavlov PS; Tasheva IG
    Folia Med (Plovdiv); 2013; 55(2):16-25. PubMed ID: 24191395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Six-month outcomes and prediction of mortality in 458 patients with acute coronary syndromes without persistent ST segment elevation assigned to early invasive strategy].
    Szyguła-Jurkiewicz B; Wilczek K; Zembala M; Mercik G; Poloński L
    Pol Arch Med Wewn; 2004 Dec; 112(6):1459-66. PubMed ID: 15962611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.
    Wallentin L; Lagerqvist B; Husted S; Kontny F; Ståhle E; Swahn E
    Lancet; 2000 Jul; 356(9223):9-16. PubMed ID: 10892758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Allhoff T; Peter T; Siegbahn A; Venge P; Drexler H; Wallentin L
    Circulation; 2007 Oct; 116(14):1540-8. PubMed ID: 17848615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin as a bridge to timely revascularization in unstable coronary artery disease -- an update of the Fragmin during Instability in Coronary Artery Disease II Trial.
    Wallentin L
    Haemostasis; 2000; 30 Suppl 2():108-13; discussion 106-7. PubMed ID: 11251353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
    JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.
    Jobs A; Mehta SR; Montalescot G; Vicaut E; Van't Hof AWJ; Badings EA; Neumann FJ; Kastrati A; Sciahbasi A; Reuter PG; Lapostolle F; Milosevic A; Stankovic G; Milasinovic D; Vonthein R; Desch S; Thiele H
    Lancet; 2017 Aug; 390(10096):737-746. PubMed ID: 28778541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Kofoed KF; Kelbæk H; Hansen PR; Torp-Pedersen C; Høfsten D; Kløvgaard L; Holmvang L; Helqvist S; Jørgensen E; Galatius S; Pedersen F; Bang L; Saunamaki K; Clemmensen P; Linde JJ; Heitmann M; Wendelboe Nielsen O; Raymond IE; Kristiansen OP; Svendsen IH; Bech J; Dominguez Vall-Lamora MH; Kragelund C; Hansen TF; Dahlgaard Hove J; Jørgensen T; Fornitz GG; Steffensen R; Jurlander B; Abdulla J; Lyngbæk S; Elming H; Therkelsen SK; Abildgaard U; Jensen JS; Gislason G; Køber LV; Engstrøm T
    Circulation; 2018 Dec; 138(24):2741-2750. PubMed ID: 30565996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.
    Fox KA; Clayton TC; Damman P; Pocock SJ; de Winter RJ; Tijssen JG; Lagerqvist B; Wallentin L;
    J Am Coll Cardiol; 2010 Jun; 55(22):2435-45. PubMed ID: 20359842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial.
    Sabate M; Cequier A; Iñiguez A; Serra A; Hernandez-Antolin R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Gómez-Hospital JA; Baz JA; Martin-Yuste V; van Geuns RJ; Alfonso F; Bordes P; Tebaldi M; Masotti M; Silvestro A; Backx B; Brugaletta S; van Es GA; Serruys PW
    Lancet; 2012 Oct; 380(9852):1482-90. PubMed ID: 22951305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Versus Delayed Invasive Strategies in High-Risk Non-ST Elevation Acute Coronary Syndrome Patients - A Systematic Literature Review and Meta-Analysis of Randomised Controlled Trials.
    Javat D; Heal C; Buchholz S; Zhang Z
    Heart Lung Circ; 2017 Nov; 26(11):1142-1159. PubMed ID: 28515027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation.
    Dijksman LM; Hirsch A; Windhausen F; Asselman FF; Tijssen JG; Dijkgraaf MG; de Winter RJ;
    Int J Cardiol; 2009 Jan; 131(2):204-11. PubMed ID: 18199496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.